Microsomal prostaglandin E2 synthase 1(mPGES-1),the main terminal synthase of prostaglandin E2(PGE2),plays a crucial role in inflammatory diseases.Compared to non-steroidal anti-inflammatory drugs(NSAIDs),mPGES-1 inhibitors are promising agents for their better specificity and higher safety.This article summarizes the research status of mPGES-1 in inflammation and cardiovascular diseases,systematically reviews the research progress of the development of mPGES-1 inhibitors,elaborates on their therapeutic effects in different inflammation animal models and inflammatory diseases,and discusses the possible existing challenges,aiming to provide some guidance and reference for the subsequent research of anti-inflammatory drugs.
万方数据